{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T22:30:26Z","timestamp":1770503426264,"version":"3.49.0"},"reference-count":59,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.1016\/j.clinthera.2009.01.001","type":"journal-article","created":{"date-parts":[[2009,2,24]],"date-time":"2009-02-24T14:52:38Z","timestamp":1235487158000},"page":"194-212","source":"Crossref","is-referenced-by-count":61,"title":["Economic evaluation of dabigatran etexilate for the prevention of venous thromboembolism after total knee and hip replacement surgery"],"prefix":"10.1016","volume":"31","author":[{"given":"Sorrel E.","family":"Wolowacz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neil S.","family":"Roskell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fiona","family":"Maciver","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen M.","family":"Beard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul A.","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan M.","family":"Plumb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerry","family":"Dolan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivan J.","family":"Brenkel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2009.01.001_bib1","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1160\/TH07-10-0611","article-title":"for the RIETE Investigators Clinical presentation and time-course of postoperative venous thromboembolism: Results from the RIETE Registry","volume":"99","author":"Arcelus","year":"2008","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.clinthera.2009.01.001_bib2","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1177\/1358836X9800300112","article-title":"Long-term outcomes after deep venous thrombosis of the lower extremities","volume":"3","author":"Prandoni","year":"1998","journal-title":"Vasc Med"},{"key":"10.1016\/j.clinthera.2009.01.001_bib3","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1001\/archinte.165.13.1458","article-title":"Antithrombotic therapy practices in US hospitals in an era of practice guidelines","volume":"165","author":"Tapson","year":"2005","journal-title":"Arch Intern Med"},{"issue":"Suppl","key":"10.1016\/j.clinthera.2009.01.001_bib5","doi-asserted-by":"crossref","first-page":"381S","DOI":"10.1378\/chest.08-0656","article-title":"Prevention of venous thromboembolism: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition)","volume":"133","author":"Geerts","year":"2008","journal-title":"Chest"},{"key":"10.1016\/j.clinthera.2009.01.001_bib7","first-page":"13621366","article-title":"Reduction of out-of-hospital symptomatic venous thromboembolism by extended thromboprophylaxis with low-molecular-weight heparin following elective hip arthroplasty: A systematic review","volume":"163","author":"O\u2019Donnell","year":"2003","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.clinthera.2009.01.001_bib8","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.2165\/00003495-200666110-00001","article-title":"Oral anticoagulants in development: Focus on thromboprophylaxis in patients undergoing orthopaedic surgery","volume":"66","author":"Eriksson","year":"2006","journal-title":"Drugs"},{"issue":"Suppl","key":"10.1016\/j.clinthera.2009.01.001_bib9","doi-asserted-by":"crossref","first-page":"349S","DOI":"10.1378\/chest.124.6_suppl.349S","article-title":"for the Hip and Knee Registry Investigators. Temporal trends in prevention of venous thromboembolism following primary total hip or knee arthroplasty 1996-2001: Findings from the Hip and Knee Registry","volume":"124","author":"Anderson","year":"2003","journal-title":"Chest"},{"key":"10.1016\/j.clinthera.2009.01.001_bib10","series-title":"Presented at: 28th Congress of the International Society on Thrombosis and Haemostasis","article-title":"Identification and in vitro characterization of BIBR 953 ZW, a novel synthetic low molecular weight direct thrombin inhibitor","author":"Stassen","year":"2001"},{"key":"10.1016\/j.clinthera.2009.01.001_bib11","doi-asserted-by":"crossref","first-page":"285","DOI":"10.2165\/00003088-200847050-00001","article-title":"Clinical pharmacokinetics and pharmacodynamics of the oral direct thrombin inhibitor dabigatran etexilate","volume":"47","author":"Stangier","year":"2008","journal-title":"Clin Pharmacokmet"},{"key":"10.1016\/j.clinthera.2009.01.001_bib12","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1111\/j.1538-7836.2007.02748.x","article-title":"for the RE-MODEL Study Group. Oral dabigatran etexilate vs. subcutaneous enoxaparin for the prevention of venous thromboembolism after total knee replacement: The RE-MODEL randomized trial","volume":"5","author":"Eriksson","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.clinthera.2009.01.001_bib13","unstructured":"The RE-MOBILIZE Writing Committee. The oral thrombin inhibitor dabigatran etexilate vs the North American enoxaparin regimen for the prevention of venous thromboembolism after knee arthroplasty surgery [published online ahead of print April 11, 2008]. J Arthroplasty."},{"key":"10.1016\/j.clinthera.2009.01.001_bib14_1","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1016\/S0140-6736(07)61445-7","article-title":"for the RE-NOVATE Study Group. Dabigatran etexilate versus enoxaparin for prevention ofvenous thromboembolism after total hip replacement: A randomised, double-blind, non-inferiority trial","volume":"370","author":"Eriksson","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.clinthera.2009.01.001_bib14_2","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/S0140-6736(07)61445-7","article-title":"for the RE-NOVATE Study Group. Dabigatran etexilate versus enoxaparin for prevention ofvenous thromboembolism after total hip replacement: A randomised, double-blind, non-inferiority trial","volume":"370","author":"Eriksson","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.clinthera.2009.01.001_bib15","doi-asserted-by":"crossref","first-page":"2993","DOI":"10.1185\/03007990802443255","article-title":"Cost-effectiveness of venous thromboembolism prophylaxis in total hip and knee replacement surgery: The evolving application of health economic modelling over 20 years","volume":"24","author":"Wolowacz","year":"2008","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.clinthera.2009.01.001_bib16","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1016\/S0149-2918(02)80091-1","article-title":"Results of an economic model to assess the cost-effectiveness of enoxaparin, a low-molecular-weight heparin, versus warfarin for the prophylaxis of deep vein thrombosis and associated long-term complications in total hip replacement surgery in the United States","volume":"24","author":"Botteman","year":"2002","journal-title":"Clin Ther"},{"key":"10.1016\/j.clinthera.2009.01.001_bib20","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1160\/TH08-07-0493","article-title":"Efficacy and safety of dabigatran etexilate for the prevention of venous thromboembolism following total hip or knee arthroplasty: A meta-analysis","volume":"101","author":"Wolowacz","year":"2009","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.clinthera.2009.01.001_bib21","series-title":"British National Formulary 56","year":"2008"},{"key":"10.1016\/j.clinthera.2009.01.001_bib22","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1023\/B:PHAR.0000035887.23072.e5","article-title":"Economic evaluation of enoxaparin for the prevention of venous thromboembolism in acutely ill medical patients","volume":"26","author":"Offord","year":"2004","journal-title":"Pharm World Sci"},{"key":"10.1016\/j.clinthera.2009.01.001_bib24","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1302\/0301-620X.88B1.17003","article-title":"Assessment of a self-administration protocol for extended subcutaneous thromboprophylaxis in lower limb arthroplasty","volume":"88","author":"Watts","year":"2006","journal-title":"J Bone Joint Surg Br"},{"key":"10.1016\/j.clinthera.2009.01.001_bib25","doi-asserted-by":"crossref","first-page":"2710","DOI":"10.1182\/blood-2005-04-1546","article-title":"Risk for heparin-induced thrombocytopenia with un fractionated and low-molecular-weight heparin thromboprophylaxis: A meta-analysis","volume":"106","author":"Martel","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.clinthera.2009.01.001_bib26","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1001\/archinte.155.7.757","article-title":"Cost-effectiveness of enoxaparin vs low-dose warfarin in the prevention of deep-vein thrombosis after total hip replacement surgery","volume":"155","author":"Menzin","year":"1995","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.clinthera.2009.01.001_bib27","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1001\/jama.257.2.203","article-title":"A cost-effectiveness analysis of prophylaxis against deep-vein thrombosis in major orthopedic surgery","volume":"257","author":"Oster","year":"1987","journal-title":"JAMA"},{"key":"10.1016\/j.clinthera.2009.01.001_bib28","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1001\/archinte.158.14.1525","article-title":"Incidence and time course of thromboembolic outcomes following total hip or knee arthroplasty","volume":"158","author":"White","year":"1998","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.clinthera.2009.01.001_bib29","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s00402-004-0720-3","article-title":"Prolonged enoxaparin therapy to prevent venous thromboembolism after primary hip or knee replacement. A cost-utility analysis","volume":"124","author":"Haentjens","year":"2004","journal-title":"Arch Orthop Trauma Surg"},{"key":"10.1016\/j.clinthera.2009.01.001_bib30","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1001\/archinte.158.8.873","article-title":"for the Canadian Collaborative Group. The incidence of symptomatic venous thromboembolism during and after prophylaxis with enoxaparin: A multi-institutional cohort study of patients who underwent hip or knee arthroplasty","volume":"158","author":"Leclerc","year":"1998","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.clinthera.2009.01.001_bib31","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1046\/j.1538-7836.2003.00396.x","article-title":"The cost-effectiveness of fonda-parinux compared with enoxaparin as prophylaxis against thromboembolism following major orthopedic surgery","volume":"1","author":"Gordois","year":"2003","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.clinthera.2009.01.001_bib33","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1046\/j.1524-4733.2000.36005.x","article-title":"Economic evaluation of enoxaparin as postdischarge prophylaxis for deep vein thrombosis (DVT) in elective hip surgery","volume":"3","author":"Davies","year":"2000","journal-title":"Value Health"},{"key":"10.1016\/j.clinthera.2009.01.001_bib34","series-title":"Presented at: 17th International Congress on Thrombosis","article-title":"Patient-reported outcomes in patients with deep vein thrombosis treated with warfarin","author":"Ingelgard","year":"2002"},{"key":"10.1016\/j.clinthera.2009.01.001_bib35","author":"Liebeskind"},{"key":"10.1016\/j.clinthera.2009.01.001_bib36","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1017\/S026646230400128X","article-title":"Major bleeding rates after prophylaxis against venous thromboembolism: Systematic review, meta-analysis, and cost implications","volume":"20","author":"Muntz","year":"2004","journal-title":"Int J Technol Assess Health Care"},{"key":"10.1016\/j.clinthera.2009.01.001_bib37","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1053\/ajem.2002.30104","article-title":"Can specific patient variables be used to predict outcome of intracranial hemorrhage?","volume":"20","author":"Dubinsky","year":"2002","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.clinthera.2009.01.001_bib38","series-title":"Presented at: 44th Annual Scientific Meeting of the British Society for Haematology","article-title":"Healthcare costs of treating bleeding and other complications associated with warfarin treatment of atrial fibrillation and venous thromboembolism in the UK","author":"Bond","year":"2004"},{"issue":"Suppl 1","key":"10.1016\/j.clinthera.2009.01.001_bib39","doi-asserted-by":"crossref","first-page":"43","DOI":"10.2165\/00019053-200321001-00005","article-title":"The economic burden of stroke in the United Kingdom","volume":"21","author":"Youman","year":"2003","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.clinthera.2009.01.001_bib40","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1258\/1355819011927288","article-title":"How patients with atrial fibrillation value different health outcomes: A standard gamble study","volume":"6","author":"Robinson","year":"2001","journal-title":"J Health Serv Res Policy"},{"key":"10.1016\/j.clinthera.2009.01.001_bib41","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0741-5214(98)70361-1","article-title":"Reduced morbidity and mortality rates of the hepann-mduced thrombocytopenia syndrome","volume":"27","author":"Almeida","year":"1998","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.clinthera.2009.01.001_bib42","doi-asserted-by":"crossref","first-page":"885","DOI":"10.2165\/00019053-200422130-00006","article-title":"Pharmacoeconomic analysis of bemipann and enoxaparin as prophylaxis for venous thromboembolism in total knee replacement surgery","volume":"22","author":"Honorato","year":"2004","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.clinthera.2009.01.001_bib43","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1046\/j.1524-4733.2003.00204.x","article-title":"Economic burden of long-term complications of deep vein thrombosis after total hip replacement surgery in the United States","volume":"6","author":"Caprini","year":"2003","journal-title":"Value Health"},{"key":"10.1016\/j.clinthera.2009.01.001_bib44","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1136\/jamia.1997.0040049","article-title":"Automated computer interviews to elicit utilities: Potential applications in the treatment of deep venous thrombosis","volume":"4","author":"Lenert","year":"1997","journal-title":"J Am Med Inform Assoc"},{"key":"10.1016\/j.clinthera.2009.01.001_bib47","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1001\/archinte.160.6.769","article-title":"Recurrent venous thromboembolism after deep vein thrombosis: Incidence and risk factors","volume":"160","author":"Hansson","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.clinthera.2009.01.001_bib48","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0049-3848(00)00370-4","article-title":"Post-thrombotic syndrome after primary event of deep venous thrombosis 10 to 20 years ago","volume":"101","author":"Ziegler","year":"2001","journal-title":"Thromb Res"},{"key":"10.1016\/j.clinthera.2009.01.001_bib49","doi-asserted-by":"crossref","first-page":"3484","DOI":"10.1182\/blood-2002-01-0108","article-title":"Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis","volume":"100","author":"Prandoni","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.clinthera.2009.01.001_bib50","first-page":"423","article-title":"The clinical course of deepvein thrombosis. Prospective long-term follow-up of 528 symptomatic patients","volume":"82","author":"Prandoni","year":"1997","journal-title":"Haematologica"},{"key":"10.1016\/j.clinthera.2009.01.001_bib51","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1056\/NEJMoa032959","article-title":"The risk of recurrent venous thromboembolism in men and women","volume":"350","author":"Kyrle","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinthera.2009.01.001_bib52","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1159\/000083827","article-title":"Risk factors of recurrent venous thromboembolism: The role of residual vein thrombosis","volume":"33","author":"Prandoni","year":"2003","journal-title":"Pathophysiol Haemost Thromb"},{"key":"10.1016\/j.clinthera.2009.01.001_bib53","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1001\/archinte.155.10.1031","article-title":"Long-term outcomes of deep-vein thrombosis","volume":"155","author":"Beyth","year":"1995","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.clinthera.2009.01.001_bib54","doi-asserted-by":"crossref","first-page":"249","DOI":"10.7326\/0003-4819-141-4-200408170-00004","article-title":"Below-knee elastic compression stockings to prevent the post-thrombotic syndrome: A randomized, controlled trial","volume":"141","author":"Prandoni","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clinthera.2009.01.001_bib55","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1007\/s10016-004-0133-3","article-title":"Comparing short-term outcomes of femoral-popliteal and iliofemoral deep venous thrombosis: Early lysis and development of reflux","volume":"19","author":"Singh","year":"2005","journal-title":"Ann Vasc Surg"},{"key":"10.1016\/j.clinthera.2009.01.001_bib56","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1001\/archinte.160.5.669","article-title":"Postthrombotic syndrome after hip or knee arthroplasty: A cross-sectional study","volume":"160","author":"Ginsberg","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.clinthera.2009.01.001_bib57","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.1365-2796.1993.tb00981.x","article-title":"Venographic assessment of deep vein thrombosis and risk of developing post-thrombotic syndrome: A prospective study","volume":"233","author":"Monreal","year":"1993","journal-title":"J Intern Med"},{"key":"10.1016\/j.clinthera.2009.01.001_bib58","first-page":"54","article-title":"Hemodynamic and clinical assessment after therapy for acute deep vein thrombosis. A prospective study","volume":"150","author":"Kakkar","year":"1985","journal-title":"Am J Surg"},{"key":"10.1016\/j.clinthera.2009.01.001_bib59","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1067\/mva.1986.avs0040436","article-title":"Long-term hemodynamic and clinical sequelae of lower extremity deep vein thrombosis","volume":"4","author":"Lindner","year":"1986","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.clinthera.2009.01.001_bib60","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1055\/s-0038-1656121","article-title":"On the relationship between changes in the deep veins evaluated by duplex sonography and the post-thrombotic syndrome 12 years after deep vein thrombosis","volume":"77","author":"Franzeck","year":"1997","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.clinthera.2009.01.001_bib61","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1042\/cs0930007","article-title":"Clinical and haemody-namic sequelae of deep venous thrombosis: Retrospective evaluation after 7\u201313 years","volume":"93","author":"Janssen","year":"1997","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.clinthera.2009.01.001_bib62","doi-asserted-by":"crossref","first-page":"595","DOI":"10.3109\/17453679408994611","article-title":"Postphlebitic syndrome after hip arthroplasty. 43 Patients followed at least 5 years","volume":"65","author":"McNally","year":"1994","journal-title":"Acta Orthop Scand"},{"key":"10.1016\/j.clinthera.2009.01.001_bib63","first-page":"57","article-title":"Clinical course and incidence of post-thrombophlebitic syndrome after profound asymptomatic deep vein thrombosis. Results of a transverse epidemiologic study [in Italian]","volume":"45","author":"Siragusa","year":"1997","journal-title":"Minerva Cardioangiol"},{"key":"10.1016\/j.clinthera.2009.01.001_bib64","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1067\/mva.2001.113308","article-title":"Trends in the incidence of venous stasis syndrome and venous ulcer: A 25-year population-based study","volume":"33","author":"Heit","year":"2001","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.clinthera.2009.01.001_bib66","series-title":"NHS Returns 2003\/4","year":"2008"},{"key":"10.1016\/j.clinthera.2009.01.001_bib67","series-title":"The Health Survey for England 1996","author":"Prescott-Clarke","year":"1998"},{"key":"10.1016\/j.clinthera.2009.01.001_bib69","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1524-4733.2005.08101.x","article-title":"Probabilistic analysis of cost-effectiveness models: Statistical representation of parameter uncertainty","volume":"8","author":"Briggs","year":"2005","journal-title":"Value Health"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291809000150?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291809000150?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,18]],"date-time":"2019-05-18T06:55:54Z","timestamp":1558162554000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291809000150"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1]]},"references-count":59,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,1]]}},"alternative-id":["S0149291809000150"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2009.01.001","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2009,1]]}}}